tirzepatide obesity trial non-diabetic after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 Tirzepatide on ingestive behavior in

diff, you and your healthcare provider may still need to talk about making changes to your medication regimen in order to better control your IBD and avoid flare-ups

However, available human studies show no consistent change in semen parameters with GLP-1-associated weight loss

Mild side effects of Ozempic and GLP-1 Drugs may include: Abdominal pain Constipation Diarrhea Burping Indigestion Acid reflux Headaches Dizziness nausea or vomiting Change in taste perception

Symptoms present, workup pending: The patient presents with pain, tingling, or numbness attributable to diabetes

Dehydration and Fluid Loss Semaglutide commonly causes nausea, vomiting, or diarrhea, particularly during treatment initiation and dose escalation